NCT02571881View on ClinicalTrials.gov

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

PHASE4UnknownINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
ConstipationPain, Postoperative
Interventions
PROCEDURE

Caesarean section

After caesarean section oxycodone or oxycodone-naloxone prolonged release tablet twice a day is started for pain medication

DRUG

Oxycodone

DRUG

oxycodone-naloxone

Trial Locations (1)

70029

Kuopio University Hospital, Kuopio

Sponsors

Collaborators (1)

Admescope Ltd
All Listed Sponsors
collaborator

Admescope Ltd

INDUSTRY

lead

Kuopio University Hospital

OTHER

NCT02571881 - Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section | Biotech Hunter | Biotech Hunter